TMCnet News
Research and Markets: Renal Anemia - Active Pharmaceutical Ingredients Insights 2015Research and Markets (http://www.researchandmarkets.com/research/3b6rbr/renal_anemiaapi) has announced the addition of the "Renal Anemia-API Insights" report to their offering. Renal Anemia-API Insights, 2015 report provides Renal Anemia drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries related to the drugs falling under Renal Anemia. The Report provides the India and China API Manufactures who are driving the current API Market. The report also highlights the patent, patent exclusivity information and competitive landscape. The research analysis also presents the global sales forecasts data for the Renal Anemia drugs till 2016. The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. Scope - A snapshot of the global Market therapeutics scenario for Respiratory Distress Syndrome. - A review of the marketed products under prescription for Respiratory Distress Syndrome, regulatory information and marketing status. - Coverage of global patent coverage and detailed commentaries on the US patent challenges. - Graphical representation of investigational products for patent expiry and market exclusivities across the globe. - Product profiles for marketed products for Respiratory Distress Syndrome with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details. - Coverage of API Manufacturers for Respiratory Distress Syndrome drugs in the United States, Europe and Asian Regions with location details. - Coverage of Regulatory filings in the US, Europe, and Asia specifically India and China for Respiratory Distress Syndrome drugs. - Key discontinued Marketed products. - Global Sales Figures from 2012-2016. For more information visit http://www.researchandmarkets.com/research/3b6rbr/renal_anemiaapi
View source version on businesswire.com: http://www.businesswire.com/news/home/20150701006331/en/ |
